Woowon Development Co., Ltd. (KOSDAQ:046940)

Ligand Pharmaceuticals Revenue

Woowon Development had revenue of 89.08B KRW in the quarter ending March 31, 2025, with 35.81% growth. This brings the company's revenue in the last twelve months to 326.33B, up 23.51% year-over-year. In the year 2024, Woowon Development had annual revenue of 302.84B with 19.93% growth.

• Revenue (ttm): 326.33B
• Revenue Growth: +23.51%
• P/S Ratio: 0.17
• Revenue / Employee: 1.30B
• Employees: 251
• Market Cap: 55.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	302.84B	50.33B	19.93%
Dec 31, 2023	252.51B	56.22B	28.64%
Dec 31, 2022	196.29B	21.99B	12.61%
Dec 31, 2021	174.30B	-142.00B	-44.89%
Dec 31, 2020	316.31B	26.10B	8.99%